Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000654612 | SCV000776506 | likely benign | Multiple endocrine neoplasia, type 2 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Institute for Clinical Genetics, |
RCV003237979 | SCV002011460 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002397328 | SCV002710710 | likely benign | Hereditary cancer-predisposing syndrome | 2020-02-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV000654612 | SCV004832074 | likely benign | Multiple endocrine neoplasia, type 2 | 2023-12-13 | criteria provided, single submitter | clinical testing |